Abstract: Ambulatory surgical and anesthesia care (ASAC), also known as Same Day Surgery or Day Care in some countries, is the fastest growing segment of ambulatory surgical and anesthesia care. Over 50 million ambulatory surgical procedures are conducted annually comprising over 60% of all anesthesia care with an impressive track record of safety and efficiency. Advances in ambulatory anesthesia care have been due to newer generation of inhalation and intravenous anesthetics as well as airway management technology and techniques. Successful ambulatory anesthesia care relies on patient selection, adequate facilities, highly trained personnel and quality improvement policies and procedures. Favoring one anesthetic technique over the other should be patient and procedure-specific. Effective management of post-operative pain as well as nausea and vomiting are the final pieces in assuring success in ambulatory anesthesia care.
Introduction
Ambulatory surgical and anesthesia care (ASAC), also known as same-day surgery or day care in some countries, is the fastest-growing segment of surgical and anesthesia care. Over 50 million ambulatory surgical procedures are conducted annually, comprising over 60% of all anesthesia care, with an impressive track record of safety and efficiency. The economics of health care as well as patient expectations have increased the need for moving more of the surgical and anesthesia care to the ambulatory setting. This article addresses the advances in techniques and the culture of safety of ASAC.
Culture of safety
In a recently published edition of Anesthesiology Clinics of North America, Fleisher 1 stated that ambulatory anesthesia is becoming the predominant type of surgical and anesthesia care provided. He stressed that the advances made in this area have been made in multiple domains, including patient comorbidity management, drug development, and regulatory issues, as well as outcome assessment. In the same edition, Apfelbaum and Cutter 2 discussed the culture of safety through what they termed the "four Ps": place, procedure, personnel, and patient.
Physical facilities where ASAC takes place can vary from a dedicated facility within a hospital, free-standing ambulatory surgical center (ASC) or office-based facility. All three settings can be very safe and appropriate, provided that the required facilities are well equipped and at the level that would be conducive to safe provision of care. Back-up systems as well as advanced airway-management techniques are very important to deal with the unexpected. Apfelbaum and Cutter place great emphasis on
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They summarized patient-related challenges in the following questions: 1. Is the patient stable enough to tolerate ASAC? 2. Can postoperative pain be managed effectively after discharge? 3. Is there a significant risk of postoperative nausea and vomiting? 4. Is there a significant risk of postoperative pathophysiologic derangements? If those risks are significant, then the patient may not be a suitable candidate for ASAC. Weiss et al 3 stated that hospital stays involving an operating room procedure were about twice as costly as those that did not involve operating room procedures. Mathis et al 4 identified those at high risk for major complications subsequent to ASAC. Of 244,397 surgeries studied, they reported a 0.1% risk of developing early perioperative morbidity. Seven independent risk factors were identified while controlling for surgical complexity: overweight body mass index, obese body mass index, chronic obstructive pulmonary disease, history of transient ischemic attacks/ stroke, hypertension, previous cardiac surgical intervention, and prolonged operative time. Hollingsworth et al 5 reported that the most prevalent ASAC procedures are ophthalmology and plastic surgery. Absent from that study were dental and oral surgery procedures, which if taken into consideration can add to the significance and extent of ambulatory surgical procedures conducted. A study conducted by the University of Michigan published by Sheetz et al 6 reported a 2.3% incidence of postoperative complications for ASAC compared to 7.4% for inpatient procedures. They attributed the wide variation in utilization of ASAC to variation in surgeon practices.
In an effort to stratify liability risk for ambulatory anesthesia Metzner and Kent 7 painted a mixed picture of reduced liability risk of ASAC, reporting a reduced number of claims for major damaging events, yet indicated that adverse events occurring after discharge remain a particular risk for liability, especially for office-based procedures.
When looking outside the US, a national Danish study published by Majholm et al 8 reported no deaths in 57,709 ASAC cases, with a 1.21% incidence of return to hospital. Gynecological, orthopedic, and gastrointestinal procedures were the most prevalent procedures, with postoperative bleeding and infection the most common two reasons for hospital returns.
Nekhendzy and Ramaiah 9 addressed the prevention of perioperative anesthesia-related complications in facial cosmetic surgery with the following general considerations: 
Culture of efficiency
Looking at 21 nonacademic facilities, Dexter et al 10 found that while inpatients scheduled for surgery accounted for 16.2% of all scheduled surgeries versus same-day surgery patients, they accounted for 49% of cancelled procedures. All same-day surgery patients had a preanesthesia assessment by phone. They accounted for 1.6% of the scheduled minutes that were canceled.
With the emergence of free-standing ASC, Hair 
Office-based anesthesia
Office-based anesthesia and surgical care is the fastest growing segment of ASAC. The number of office-based procedures increased to 10 million procedures per year from 1995 to 2005. 13 Safety data vary greatly among different studies, as outlined by Shapiro et al. 14, 15 They indicated that while some authors focused on plastic surgery outcomes, particularly liposuction and abdominoplasty, which might carry a higher risk regardless of duration of surgery, which seems not to be a contributing factor, 16 other studies looked at office-based procedures across the board and found low complications during these procedures, with evidence of morbidity and mortality profiles similar to those of other ambulatory settings. As is the case with any other setting, the safety criteria and practices that were outlined earlier should be adhered to in order to reduce the risk of adverse outcomes. An emphasis on continuous quality improvement, safety checklists, and outcome data reporting is very important to ensure high levels of safety and quality while fostering a culture of efficiency and cost-effectiveness.
Airway management
Significant advances in airway-management technology and anesthetic quality and safety have taken place in the past 25 years. In this segment, some of those advancements with regard to safe airway management will be outlined.
Laryngeal mask airway
The LMA is a supraglottic device that facilitates airway ventilation without tracheal intubation. It is inserted primarily through a blind technique, with some variations depending on the type of LMA being utilized. There are several designs that have evolved since the initial introduction of the LMA into clinical use that can facilitate ventilation and serve as conduits in tracheal intubation and for suction of secretion, as well as improve the airway seal to minimize intrapulmonary aspiration. Use of the LMA in ambulatory anesthesia is common, and has been proven to be safe and effective. 17 In ambulatory pediatric ophthalmologic procedures, a retrospective study showed that the insertion of an LMA without the need of intravenous access was both safe and effective. 18 ProSeal LMA was found to create a better seal from gastric aspiration, but was more challenging to insert. 19 The selection of the type of LMA for use should be procedure-and patient-dependent and at the discretion of the anesthesiologist. In general, LMA utilization has the following limitations: 1. limited eff icacy in delivering high peak airway pressures 2. carries a certain risk of intrapulmonary aspiration 3. may interfere with certain procedures, particularly intraoral and laryngeal procedures.
video-assisted laryngoscopy
Videolaryngoscopy emerged into clinical use over 10 years ago. It has provided an added level of sophistication to advanced airway management. Studies have demonstrated a higher success rate with videolaryngoscopy versus conventional direct laryngoscopy. [20] [21] [22] This provides a significant advantage in the ambulatory setting in efforts to improve quality of care and minimize airway trauma or intubation failure. Multiple designs of video-assisted laryngoscopes have emerged, including compact designs that can be quite valuable in office-based and mobile anesthesiology settings. As in any other techniques, limitations pertain to technical difficulties, fluid and blood contamination of the camera, and failure to visualize the glottis.
Flexible-tip endotracheal tubes
In an effort to improve quality of care and minimize airway trauma, flexible-tip endotracheal tubes offer considerable promise. A flexible tip that has been incorporated in the manufacturing process of these endotracheal tubes offers a less traumatic alternative during nasal and oral endotracheal intubation. [23] [24] [25] Flexible-tip endotracheal tubes require some adaptation when conducting a nasal intubation technique, and might require some practice before the provider is fully proficient in utilizing them, but they can be useful tools in the effort to minimize airway-intubation trauma. More double-blind studies are needed to confirm their advantage over conventional endotracheal tubes.
Advancements in anesthetic techniques
An ideal anesthesia technique is one that has fast onset and fast recovery, with minimal cardiovascular and side effects. While science is still in search of the holy grail of anesthesia care, many advances have been made in the past two decades 
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inhalation anesthesia
Volatile inhaled anesthetics have been the backbone of surgical anesthesia care. Several agents have been developed since the 1950s that have significantly improved the safety track record of this class of drugs. The introduction of sevoflurane and desflurane as part of patient care in the 1990s further improved patient-safety outcomes, especially in the areas of induction and recovery.
Sevoflurane
Sevoflurane provides several advantages as a mask induction agent in comparison with halothane, which had been used for such purposes for several decades. While both agents provide minimal upper-airway irritability, sevoflurane has far fewer cardiovascular suppressive effects and lesser risk of cardiac arrhythmia. Sevoflurane has a blood-gas partition coefficient of 0.69 and blood-brain coefficient of approximately 1.7, which is significantly lower than the older-generation volatile anesthetics, thus facilitating faster induction and faster recovery. Reduction of systemic vascular resistance is dose-dependent and comparable to other agents. As a potent bronchodilator, sevoflurane is a safe agent for individuals with asthma and reactive airway disease. Compared to halothane, sevoflurane has a significantly higher incidence of delirium and agitation in children, 26 requiring intervention to improve the quality of recovery.
Desflurane
With a blood-gas partition coefficient of approximately 0.42 and brain-blood partition coefficient of approximately 1.3, desflurane has demonstrated significantly faster recovery characteristics with minimal redistribution, making it the inhalation agent of choice for the obese patient. Being a highly irritant agent to the upper airway, desflurane is not an agent of choice for mask induction, due to serious concerns with inducing laryngospasm. Its boiling point at room temperature requires the need for a special vaporizer for administration of desflurane.
All volatile anesthetics are trigger agents for malignant hyperthermia, requiring the presence of dantrolene sodium in the facility, and are an absolute contraindication for patients with such history. Both sevoflurane and desflurane come at a much higher cost compared to isoflurane and halothane.
With those two newer agents offering several advantages over the older-generation anesthetics, the verdict is not completely out on which is more advantageous compared to the other. White et al 27 evaluated 130 patients undergoing superficial outpatient surgeries. All patients were induced with propofol and maintained with either sevoflurane or desflurane with an LMA as the airway of choice. The desflurane group had 60% incidence of coughing compare to 32% for sevoflurane. Emergence from anesthesia was more rapid in the desflurane group, however, in the late recovery period there was no significant difference between the two groups.
In a smaller study involving adults undergoing a laryngoscopy procedure, Nathanson et al 28 reported similar outcomes compared to the White et al study, with similar outcomes regarding PONV and patient acceptance of the anesthetic for future procedures. It is worth mentioning that a metaanalysis study published by Dexter and Tinker 29 showed a mean discharge time for desflurane group only 4.4 minutes faster than the isoflurane group, while the propofol group was 17 minutes faster than the desflurane group.
intravenous anesthetics
There is a growing trend in ASAC for utilization of intravenous anesthetics as the sole technique for provision of ambulatory anesthesia care, also known as total intravenous anesthesia. This came about as a result of the advancement in pharmacokinetics and dynamics of injectable anesthetic agents, as well as the better clinical outcomes of several of those anesthetics. This segment will address the impact of several newer intravenous anesthetics on the evolution of ambulatory anesthesia. It is important for the anesthesia provider not to be locked in a single technique, since patient needs and circumstances vary, and often different techniques, as well as hybrid techniques, between inhalation and intravenous anesthetics may be the best approach in a particular situation.
Propofol
Propofol was initially developed in Europe in the late 1970s, and was then removed from the market, due to anaphylactic reactions related to the vehicle solution. It was reintroduced in the mid 1980s, and has become the most commonly utilized intravenous induction agent. Propofol is a diisopropyl anesthetic agent with soy oil and egg phospholipid as part of the preparation. Favorable clinical effects include rapid onset and recovery, as well as potent amnestic effects and reduction of PONV. Propofol should be used with caution in patients with significant cardiac failure, due to its possible depressive effect on cardiac output and systemic vascular resistance. Propofol can be utilized as a single-dose induction agent and for continuous infusion at general anesthesia and deep-sedation levels, as well as in combination with other intravenous agents. Concerns regarding soy allergies and egg-lecithin allergies should be taken into consideration when using propofol.
Fospropofol is a water soluble prodrug of propofol that was introduced for patient care in 2008. Fospropofol has slower onset and longer duration, but can be a possible alternative to propofol. The cost difference between the two agents significantly favors propofol.
Remifentanil
A synthetic opioid agonist with potency similar to fentanyl yet metabolized by plasma esterases, remifentanil has a half-life shorter than 5 minutes. This makes remifentanil an effective opioid analgesic without the concerns of prolonged effects due to redistribution or context sensitivity. Remifentanil can be administered as a continuous infusion over the course of the procedure, with clinical effects resolving within minutes after discontinuing the infusion. It can be administered both at an analgesic or sedative level. This makes it particularly useful for the obese patient and for patients with obstructive sleep apnea. Due to a predominant µ-receptor effect, remifentanil can cause analgesia, respiratory depression, depression of cardiac output, and systemic vascular resistance, as well as chest rigidity. Remifentanil should be used with caution in the elderly population and individuals with significant cardiac failure.
Dexmedetomidine
This is an α2-receptor agonist that has a high concentration in the locus coeruleus, where it exercises inhibitory effects inducing sleep-like anesthesia. Due to its presence in the sympathetic pre-and postsynaptic areas, it prevents the release of norepinephrine from the presynaptic storage. An α1-antagonist effect adds to its complex clinical effects, which include, sedation, reduction in blood pressure and heart rate, and analgesia with minimal respiratory depression. Dexmedetomidine is useful as an adjunct agent for patients who require lesser use of narcotics. A loading dose of 0.5-1.0 µg/kg is given over 10 minutes, and if needed an infusion of 0.2-0.7 µg/kg/h can follow. While dexmedetomidine is useful as an adjunct agent with other anesthetics, its effect as a single-agent sedative for third molar surgery was not as impressive as when combined with a small dose of midazolam, according to Smiley and Prior. 30 is total intravenous anesthesia more advantageous than inhalation anesthesia?
Lebenbom-Mansour et al 31 evaluated 60 patients undergoing orthopedic surgery who were divided into four groups: group 1, propofol induction followed by desflurane/nitrous maintenance; group 2, propofol induction followed by propofol/nitrous maintenance; group 3, desflurane/nitrous induction and maintenance; and group 4, desflurane induction and maintenance. While the quality of induction was inferior in groups 3 and 4, there was more rapid emergence in group 4 compared to the other three groups. Intermediate recovery showed no significant difference between groups 2 and 4, which were faster than groups 1 and 3. Group 3 had the most PONV incidents of all four groups.
In a multicenter study of patients undergoing knee arthroscopy, Raeder et al 32 compared maintenance of anesthesia with sevoflurane versus propofol infusion; the sevoflurane group had faster recovery but increased incidence of PONV. Hemodynamic side effects were minimal in both groups.
In another study, 33 60 patients undergoing laparoscopic cholecystectomy received desflurane or propofol for anesthetic maintenance; while the desflurane group woke up faster, they had a significantly higher incident of PONV and pain in the recovery phase. When comparing vital capacity induction using sevoflurane versus intravenous induction with propofol, Philip et al 34 reported faster induction and higher patient satisfaction in the sevoflurane group among adults undergoing ambulatory surgery.
Tang et al 35 compared two groups of spontaneously breathing patients who received either desflurane or propofol anesthesia. Patient mobility during surgery was observed more significantly in the propofol group, while desflurane recovery was significantly faster. In order to bring desflurane PONV incidence down to a comparable level to the propofol group, the desflurane group had to receive a triple PONV prophylaxis with ondansetron, droperidol, and metoclopramide.
The literature does not offer compelling evidence for the advantage of one technique versus the other in improving recovery profile and cognitive function. 36, 37 Further large-scale studies need to be conducted to validate either technique. This leaves the door open to a patient-specific and procedure-specific protocol with combined inhalation and intravenous techniques as promising for superior outcome. Combined intravenous techniques can also be applied utilizing infusion of propofol/ketamine, propofol/remifentanil, or propofol/dexmedetomidine.
electroencephalography-driven monitoring
The concept of electroencephalography-driven level of consciousness monitoring has existed for several decades. In the late 1980s, the development of bispectral index monitoring ushered in a new era in the utilization of electroencephalography-driven depth of anesthesia monitoring, promising improved and faster extubation and recovery. [38] [39] [40] [41] [42] Utilizing this technology shows promise in providing feedback regarding depth of anesthesia as a prelude to tracheal intubation without the use of neuromuscular blocking agents. 43 Ambulatory anesthesia and postoperative course of recovery Provision of anesthesia care includes the management of postsurgical pain and PONV. Jakobsson 44 described a multimodal approach to pain management comprising lowdose narcotics, nonsteroidal anti-inflammatory drugs, oral acetaminophen, and intravenous dexamethasone.
How about regional versus general anesthesia?
A meta-analysis 45 of regional versus general anesthesia did not show an advantage of one technique versus the other in reduction of surgical time. Unique circumstances regarding patientspecific history or surgical procedure may impact the decision to choose one versus the other. De Oliveria et al 46 published a meta-analysis of multiple studies validating that the systemic use of magnesium can significantly reduce postoperative pain regardless of the type of anesthesia provided.
PONv management
Management of PONV is also very important in creating favorable postoperative recovery conditions. Gan et al 47 recently published consensus guidelines for the management of postoperative nausea and vomiting. The consensus includes: 1. identification of patients with highest risk, particularly females, under age 50 years with previous history of PONV 2. procedures with higher risk of PONV, such as strabismus 3. minimizing the use of nitrous oxide and inhalation agents 4. minimizing the use of postoperative narcotics 5. preemptive prophylaxis with 5-HT 3 -receptor antagonists (eg, ondansetron) and steroids (eg, dexamethasone).
Accreditation of ambulatory facilities and mobile anesthesiology organizations
The Accreditation Association for Ambulatory Health Care, as well as the Joint Commission, provide accreditation mechanism for ambulatory facilities, office-based surgical facilities, and mobile anesthesiology organizations. The American Association for Accreditation of Ambulatory Surgery Facilities provides accreditation for ambulatory surgical facilities. The value of accreditation is in creating guidelines for nationally accepted standards of care and quality improvement. It provides the organizations and providers with a framework to follow in clinical care, record keeping, benchmarking, and quality improvement. While logistical burdens might discourage some providers from voluntarily pursuing accreditation, it is very clear that many regulatory bodies and third-party reimbursement providers will be attaching compensation of care to outcome documentation and accreditation.
Organizations that have pursued such a path voluntarily might have an advantage over those that will follow suit. The Anesthesia Patient Safety Foundation (patient-outcome registry), sponsored by the American Society of Anesthesiologists, as well as the Society for Ambulatory Anesthesia Clinical Outcomes Registry, sponsored by the Society for Ambulatory Anesthesia and recently endorsed by the American Society of Dentist Anesthesiologists, provide a forum for collating safety outcomes of anesthesia care in the ambulatory setting. It would be an ambitious but worthy goal to aim for a national project to collect such data in the entire US. This could positively impact the future of ambulatory anesthesia care.
Conclusion
Ambulatory anesthesia in its different settings is safe, efficient, and cost-effective. Employing evidence-based anesthetic techniques as well as scientifically proven methods for controlling pain and PONV are essential for successful outcomes. Safety measures, such as patient-safety checklists, staff training, employment of highly trained providers, and adequate patient selection, can positively impact patient safety and satisfaction. With the continued advancement in the science and technology of anesthesia care, we can anticipate better and safer outcomes in the future for patient anesthesia care in the ambulatory setting.
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